Apple decides to temporarily halt some Apple Watch sales amidst patent dispute.

• Apple will temporarily halt sales of two new Apple Watches, starting on Thursday.
• The Blood Oxygen feature is at the center of an intellectual property dispute between Apple and Masimo.
• The Apple Watch Series 9 and Apple Watch Ultra 2 online sales will stop at 3 p.m. on Thursday, while in-store sales will end after Sunday.

The company announced that it will pause U.S. sales of two of its latest Apple Watches due to an intellectual property dispute over their Blood Oxygen feature.

The restriction on Apple's ability to sell products with the Blood Oxygen feature is due to two orders issued by the U.S. International Trade Commission on Oct. 26, resulting from a dispute over intellectual property between Apple and a medical technology company.

Apple Watch Series 9 and Apple Watch Ultra 2 online sales will stop at 3 p.m. on Thursday, while in-store sales will end on Sunday.

Apple began a pause of its sales of certain products in the US early, giving the White House 60 days to review the restrictions per ITC policy, or until Dec. 25, to ensure compliance with the order if the ITC ruling holds up.

On Monday, Apple's stock experienced a slight decline of less than 1%, while Masimo reported a gain of more than 3%.

The FTC document reveals that one of the ITC's orders will prohibit Apple and its affiliates from importing watches with the Blood Oxygen feature, as well as the materials used to create it. Additionally, the ITC's second order demands that Apple cease selling products that utilize the Blood Oxygen feature.

If the ITC's order is upheld, Apple intends to take immediate action to resume selling both watches.

According to Apple, individuals who have already purchased either of the two Apple Watches in question will not encounter any problems with their product, and there have been no changes to the availability of either model outside of the U.S.

In the last quarter, Apple's wearables, home, and accessories unit was the third-largest source of revenue for the company, generating $9.3 billion.

Apple has stated that it strongly disagrees with the order and is taking legal and technical measures to ensure that the Apple Watch is accessible to customers.

The ITC ruling demonstrates that even the most powerful corporations must comply with the law, as stated by Masimo.